ArticleBMC infectious diseases2012

Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.

Santiago Grau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.